Protocol 2: the balanced approach (most common) Goal: Reduce side effects while reaching therapeutic doses in a reasonable timeframe Best for: First-time users, people who want a smoother experience than standard titration, those working with compounded formulations Complete schedule: Weeks 1-2: 0.25 mg weekly Weeks 3-4: 0.5 mg weekly Week 5: 1.0 mg weekly Weeks 6-7: 1.5 mg weekly Week 8-9: 2.0 mg weekly Weeks 10-13: 2.5 mg weekly Weeks 14-17: 5.0 mg weekly Time to therapeutic dose: 13-17 weeks Expected results: Mild GI effects at most transitions, noticeable appetite suppression by weeks 6-8, meaningful weight loss beginning around weeks 10-13 This is the protocol most practitioners recommend when patients specifically request microdosing
Fiber fermentation, gut microbiome activity, protein digestion, and circadian rhythm alignment all contribute to endogenous GLP-1 production
This decline is one reason why we often feel "slower" to recover from exercise or late nights as we get older
A mechanical bowel obstruction may cause severe cramping, abdominal swelling, vomiting, and an inability to pass gas or stool
Cannabis introduces a second agent affecting nausea, appetite, and liver metabolism
Anti-aging and longevity effects The longevity research on MOTS-c may be its most compelling aspect